Genome Technologies, LLC. (GT) is a research-driven biotechnology/ genomics company. Our aim is the discovery of disease-causing genes and key genetic and molecular markers with a variety of applications.

Genome Technologies has developed a powerful Functional Genomic Fingerprinting (FGF) technology that can be used to rapidly identify the defective genes that cause genetic diseases. This novel genomics technology can be applied to reveal the genetic basis of major illnesses such as hypertension, type II diabetes, allergies, asthma, and Alzhiemer’s disease; and it can identify the offending genetic defects in less time and at a significantly reduced cost than could be achieved with other existing genomic research techniques.

This platform technology can be used to enable pharmaceutical, agricultural and diagnostic companies to develop their future products rapidly and at a highly reduced cost.

This unique technology is possible at Genome Technologies because our professionals have extensive experience and capabilities in bioinformatics and computational biology, and a deep understanding of genome biology, especially as it relates to human morphology and physiology.